Quotation in Aptinyx will resume at 4:30pm E.T., acc Shares have been halted ahead of the company’s announcement that its Phase 2 Study of NYX-458 did not demonstrate sufficient efficacy in patients with cognitive impairment associated with Parkinson’s disease and dementia with Lewy bodies.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on APTX: